InterMune (nasdaq)ITMN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InterMune (nasdaq)ITMN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Secret_Agent_Man who started this subject	10/7/2002 8:39:27 AM
From: IRWIN JAMES FRANKEL	Read Replies (1) of 508

ITMN presentation at UBS Actually it added very little to our knowledge. Mainly a rehash. They reiterated guidance of over $100 M in revenue for 2002, $200 M in '03 and turning profitable in 2H04. There was PR today that they are making progress with Maxygen in makeing a once-a-week dose of Actimmune. That might improve the effectiveness of the drug as it has with other interferons. ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next